Daniela Semedo, PhD,  —

A single mother from the American Midwest with sarcoidosis has started a crowdfunding campaign on the GoFundMe platform to move to a warmer climate to improve her life. The campaign has been described as one of GoFundMe’s most important and life-changing of 2017. Stephanie Jordan of Calumet City, Illinois,…

Penn Medicine recently launched a new Apple ResearchKit app for people with sarcoidosis. The app is a personalized tool designed to deliver informational resources about sarcoidosis, provide links to advocacy groups, as well as information about local specialists and support groups based on the iPhone’s GPS. Users of the app can also…

Araim Pharmaceuticals recently announced that its lead candidate, Innate Repair Receptor (IRR) activator ARA 290, has been designed an orphan drug for the treatment of sarcoidosis by the U.S. Food and Drug Administration (FDA). ARA 290, a synthetic 11-amino acid peptide IRR agonist, is currently in Phase 2 clinical trials as a potential treatment…